Physiologic AL varies materially with age, sex, height, and ethnicity, undermining fixed AL thresholds as broadly applicable risk stratifiers in typical pediatric myopia. Retinal pathology risk ...
Introduction: Glaucoma is a major cause of irreversible blindness, with particularly high prevalence and aggressiveness in Africa. Nicknamed the ‘silent thief of sight ...
Glaucoma is the leading cause of blindness in the United States.
When text on street signs starts to blur or night driving feels harder than it used to, choosing a certified ophthalmologist in Cape Coral becomes less of ...
Addison-based Premier Vision of Dallas is helping families understand childhood myopia and the importance of early ...
This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global ...
Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.
Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...
Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...
Introduction As the world population ages, glaucoma is becoming an increasingly significant cause of blindness. A key component in the management of glaucoma is the use of prescribed medications and ...
US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...
SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its initial public offering last month with a big boost from Wall Street.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results